J M Croke1, S El-Sayed. 1. Division of Radiation Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON.
Abstract
PURPOSE: Multidisciplinary cancer conferences (mccs) are designed to optimize patient outcomes. It appears intuitive that mccs are essential to clinical decision-making and patient management; however, it is unclear whether that belief is supported by evidence. Our objectives were to assess the currently published literature addressing the impact of mccs on clinical decision-making and patient outcomes. METHODS: Ovid medline was searched from 1950 to June 2010 using these keywords: "multidisciplinary/interdisciplinary/clinical meeting$/conference$/round$/team$," "decision making," "neoplasms$/cancer$/oncology/tumo(u)r conference$/board$/meeting$," "multidisciplinary/interdisciplinary cancer conference$/meeting$." All trials, guidelines, metaanalyses, reviews, and prospective and retrospective studies were included. RESULTS: The keywords retrieved 595 abstracts, and 30 manuscripts were obtained. Most of the studies assessed the impact of mccs on clinical decision-making rather than on patient outcomes. CONCLUSIONS: Available evidence supports the belief that mccs significantly influence clinical decision-making and treatment recommendations. In contrast, scant evidence suggests that mccs improve patient outcomes. Unfortunately, the current literature is substantially heterogeneous and therefore does not allow for firm conclusions.
PURPOSE:Multidisciplinary cancer conferences (mccs) are designed to optimize patient outcomes. It appears intuitive that mccs are essential to clinical decision-making and patient management; however, it is unclear whether that belief is supported by evidence. Our objectives were to assess the currently published literature addressing the impact of mccs on clinical decision-making and patient outcomes. METHODS: Ovid medline was searched from 1950 to June 2010 using these keywords: "multidisciplinary/interdisciplinary/clinical meeting$/conference$/round$/team$," "decision making," "neoplasms$/cancer$/oncology/tumo(u)r conference$/board$/meeting$," "multidisciplinary/interdisciplinary cancer conference$/meeting$." All trials, guidelines, metaanalyses, reviews, and prospective and retrospective studies were included. RESULTS: The keywords retrieved 595 abstracts, and 30 manuscripts were obtained. Most of the studies assessed the impact of mccs on clinical decision-making rather than on patient outcomes. CONCLUSIONS: Available evidence supports the belief that mccs significantly influence clinical decision-making and treatment recommendations. In contrast, scant evidence suggests that mccs improve patient outcomes. Unfortunately, the current literature is substantially heterogeneous and therefore does not allow for firm conclusions.
Authors: R Chekerov; C Denkert; D Boehmer; A Suesse; A Widing; B Ruhmland; A Giese; A Mustea; W Lichtenegger; J Sehouli Journal: Int J Gynecol Cancer Date: 2007-04-27 Impact factor: 3.437
Authors: Nam P Nguyen; Paul Vos; Howard Lee; Thomas L Borok; Ulf Karlsson; Tomas Martinez; James Welsh; Deirdre Cohen; Russell Hamilton; Nga Nguyen; Ly M Nguyen; Vincent Vinh-Hung Journal: Oncology Date: 2008-10-08 Impact factor: 2.935
Authors: Ohad Ronen; K Thomas Robbins; Remco de Bree; Orlando Guntinas-Lichius; Dana M Hartl; Akihiro Homma; Avi Khafif; Luiz P Kowalski; Fernando López; Antti A Mäkitie; Wai Tong Ng; Alessandra Rinaldo; Juan P Rodrigo; Alvaro Sanabria; Alfio Ferlito Journal: Eur Arch Otorhinolaryngol Date: 2021-05-12 Impact factor: 2.503
Authors: Eleonore V Grant; Adam H Skolnick; Joshua Chodosh; Michael H Perskin; Nicole M Orr; Caroline Blaum; John A Dodson Journal: J Am Geriatr Soc Date: 2018-03-15 Impact factor: 5.562
Authors: Benjamin W Lamb; Rozh T Jalil; Nick Sevdalis; Charles Vincent; James S A Green Journal: BMC Health Serv Res Date: 2014-09-08 Impact factor: 2.655